Image

North America Antimicrobial Susceptibility Testing Market – Industry Trends and Forecast to 2030

Medical Devices

Image

North America Antimicrobial Susceptibility Testing Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Upcoming Report
  • Oct 2023
  • North America
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

North America Antimicrobial Susceptibility Testing Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 1,814.88 USD Million
Diagram Market Size (Forecast Year) USD 2,827.80 USD Million
Diagram CAGR %

Major Markets Players

  • BD
  • Synbiosis
  • Zhuhai DL Biotech Co. Ltd
  • Mast Group
  • HiMedia Laboratories

North America Antimicrobial Susceptibility Testing Market, By Product Type (Instruments, Consumables and Accessories and Services and Software),  Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods and Others),  Type (Antibacterial Testing, Antifungal Testing and Rapid-AST), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Others),  End-User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres and Academic Institutes and Others),  Distribution Channel (Direct Sales, Retail Sales and Third Party Distributor) – Industry Trends and Forecast to 2030.

North America Antimicrobial Susceptibility Testing Market

North America Antimicrobial Susceptibility Testing Market Analysis and Size

The North America antimicrobial susceptibility testing (AST) market continues to exhibit strong growth prospects, driven by the increasing prevalence of antibiotic-resistant infections in the region. Rising awareness about the importance of accurate susceptibility testing to guide effective antibiotic therapy and combat antimicrobial resistance has been a key catalyst for market expansion. Technological advancements in AST methods and the integration of automated systems have enhanced testing efficiency and accuracy.

Data Bridge Market Research analyses that the North America antimicrobial susceptibility testing market which was USD 1,814.88 million in 2022, is expected to reach USD 2,827.80 million by 2030, and is expected to undergo a CAGR of 5.70% during the forecast period. “Instruments” dominates the product type segment of the antimicrobial susceptibility testing market owing to the growing demand for instruments for antimicrobial testing. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

North America Antimicrobial Susceptibility Testing Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Instruments, Consumables and Accessories and Services and Software),  Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods and Others),  Type (Antibacterial Testing, Antifungal Testing and Rapid-AST), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Others),  End-User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres and Academic Institutes and Others),  Distribution Channel (Direct Sales, Retail Sales and Third Party Distributor)

Countries Covered

U.S., Mexico, Canada

Market Players Covered

BD (U.S.), Synbiosis (U.K.), Zhuhai DL Biotech Co., Ltd (China), Mast Group Ltd. (U.K.), HiMedia Laboratories (India), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Creative Diagnostics (U.S.), Genefluidics, Inc. (U.S.),  Rosco Diagnostica A/S (Denmark), ERBA Group (India), Liofilchem S.r.l. (Italy), Alifax S.r.l. (Germany), MERLIN Gesellschaft für mikrobiologische Diagnostika mbH (Germany), bioMérieux SA (France), Merck KGaA (Germany), Danaher (U.S.), Accelerate Diagnostics, Inc. (U.S.), NuMedii, Inc. (U.S.), and BacterioScan, Inc. (U.S.)

Market Opportunities

  • Growing adoption of telehealth and remote monitoring solutions
  • Technological advancements and product innovation
  • Rising research and development opportunities

Market Definition

Antimicrobial susceptibility testing (AST) is a laboratory procedure which is used to determine which antimicrobial impedes the growth of bacteria, fungi, and other microorganism causing a specific infection. Susceptibility testing is performed on microorganisms such as bacteria, fungi causing the infection after they have been recovered in a culture of the specimen.

Antibacterial drugs are playing the important role in the prevention of infectious diseases, however, the cases of drug misuse and overuse, led to the development of drug resistance. Delay in diagnosing the harmful microbes makes it difficult to control the spread of infectious diseases. This is putting pressure on the key players to manufacture the test kits which gives accurate and effective results to better treat the patients.            

North America Antimicrobial Susceptibility Testing Market Dynamics

Drivers

  • Rising Antibiotic Resistance

Increasing prevalence of antibiotic-resistant bacterial infections necessitates accurate antimicrobial susceptibility testing to guide effective antibiotic treatment. The growing concern about antimicrobial resistance is a significant driver for the market as healthcare providers seek better diagnostic tools to combat this global health threat.

  • Technological Advancements in Antimicrobial Susceptibility Testing

Ongoing advancements in AST technologies, including automated systems, molecular diagnostics, and faster testing methods, enhance the efficiency and accuracy of susceptibility testing. These innovations drive market growth as healthcare facilities seek more precise and timely results.

  • Demand for Infection Control

The COVID-19 pandemic has highlighted the importance of robust diagnostic capabilities and infection control measures. Healthcare facilities are investing in AST solutions to improve their diagnostic infrastructure, as infections become a major focus for public health.

  • Growing Investment for Healthcare Facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

  • Rising Demand for Research and Development

Continued investment in research and development can lead to the creation of novel susceptibility testing techniques and the discovery of new biomarkers. Innovations in testing methods, such as genotypic and phenotypic assays, can open new avenues for personalized and precision medicine, creating opportunities for companies to develop and commercialize these cutting-edge technologies.

  • Telemedicine and Remote Consultations

The rise of telemedicine and remote consultations offers an opportunity for companies to develop AST solutions that can integrate seamlessly with virtual healthcare platforms. These solutions can enable healthcare providers to discuss test results and treatment options remotely, improving patient access to care and convenience.

Restraints/ Challenges

  • High Cost of Antimicrobial Susceptibility Testing

The initial investment and ongoing operational costs associated with advanced AST technologies can be prohibitive for some healthcare facilities, particularly smaller or resource-constrained settings. High costs can limit the adoption of these technologies and restrict market growth.

  • Limited Healthcare Infrastructure in Underserved Areas

In some rural or underserved areas, healthcare facilities may lack the infrastructure and resources needed for advanced antimicrobial susceptibility testing. This limitation can hinder market penetration and equitable access to advanced diagnostic tools.

  • Data Integration and Interoperability

The integration of AST data into electronic health records (EHRs) and healthcare information systems can be a challenge. Ensuring that the results of susceptibility testing are easily accessible to healthcare providers and that different AST systems can communicate with EHRs is crucial for streamlined patient care.

  • Laboratory Capacity and Workforce

There is a shortage of skilled laboratory professionals capable of conducting AST and interpreting results accurately. The demand for susceptibility testing is increasing, and healthcare facilities may struggle to find and retain qualified staff to meet this demand. This challenge can lead to delays in test processing and result reporting.

This antimicrobial susceptibility testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Antimicrobial Susceptibility Testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In May 2022, Qualigen Therapeutics announced that NanoSynex Ltd, a company with whom Qualigen recently entered into definitive agreements to acquire a majority stake, featured at BioMed Israel. Innovative Technology by NanoSynex focuses to accelerate antimicrobial susceptibility test results times by six-fold
  • In April 2022, COPAN Diagnostics demonstrated its range of fully automated solutions for identification and antimicrobial susceptibility testing (AST) in clinical microbiology at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022). COPAN demonstrated the Food and Drug Administration-cleared Colibri, a fully automated specimen workup instrument designed to prepare MALDI-TOF ID targets and create bacterial suspensions for AST

North America Antimicrobial Susceptibility Testing Market Scope​​​​​​​

The antimicrobial susceptibility testing market is segmented on the basis of product type, methods, type, application, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Instruments
  • Consumables and accessories
  • Services and software

Methods       

  • Mass Spectrometry Method
  • Dilution
  • Disk Diffusion
  • E-test, Genotypic Methods
  • Others

Type

  • Antibacterial Testing
  • Antifungal Testing
  • Others

Application

  • Clinical Diagnostics
  • Drug Discovery and Development
  • Epidemiology
  • Others

End-User

  • Hospitals
  • Pharmaceuticals and Biotechnology Companies
  • Diagnostic Laboratories
  • Contract Research Organizations
  • Research Centres and Academic Institutes
  • Others

Distribution Channel

  • Direct Sales
  • Retail Sales
  • Third Party Distributor

Antimicrobial Susceptibility Testing Market Regional Analysis/Insights

The antimicrobial susceptibility testing market is analysed and market size insights and trends are provided by product type, methods, type, application, end-user and distribution channel as referenced above.

The countries covered in the antimicrobial susceptibility testing market report are U.S., Canada and Mexico in North America.

U.S is dominating in North America market due rise in epidemic and pandemic events and presence of sophisticated healthcare infrastructure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and North America Antimicrobial Susceptibility Testing Market Share Analysis

The antimicrobial susceptibility testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to antimicrobial susceptibility testing market.

Some of the major players operating in the antimicrobial susceptibility testing market are:

  • BD (U.S.)
  • Synbiosis (U.K.)
  • Zhuhai DL Biotech Co., Ltd (China)
  • Mast Group Ltd. (U.K.)
  • HiMedia Laboratories (India)
  • Thermo Fisher Scientific Inc.(U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Creative Diagnostics(U.S.)
  • Genefluidics, Inc. (U.S.)
  • Rosco Diagnostica A/S (Denmark)
  • ERBA Group (India)
  • Liofilchem S.r.l. (Italy)
  • Alifax S.r.l. (Germany)
  • MERLIN Gesellschaft für mikrobiologische Diagnostika mbH (Germany)
  • bioMérieux SA (France)
  • Merck KGaA (Germany)
  • Danaher (U.S.)
  • Accelerate Diagnostics, Inc. (U.S.)
  • NuMedii, Inc. (U.S.)
  • BacterioScan, Inc. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The North America antimicrobial susceptibility testing market size will be worth USD 2,827.80 million by 2030.
The growth rate of the North America antimicrobial susceptibility testing market is 5.70% in the forecast period by 2030.
Increasing prevalence of antibiotic-resistant bacterial infection & technological advancements in antimicrobial susceptibility testing are the growth drivers of the North America antimicrobial susceptibility testing market.
Product type, methods, type, application, end-user and distribution channel are the factors on which the North America antimicrobial susceptibility testing market research is based.
Major companies in the North America antimicrobial susceptibility testing market are BD (U.S.), Synbiosis (U.K.), Zhuhai DL Biotech Co., Ltd (China), Mast Group Ltd. (U.K.), HiMedia Laboratories (India), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Creative Diagnostics (U.S.), Genefluidics, Inc. (U.S.), Rosco Diagnostica A/S (Denmark), ERBA Group (India), Liofilchem S.r.l. (Italy), Alifax S.r.l. (Germany), MERLIN Gesellschaft für mikrobiologische Diagnostika mbH (Germany), bioMérieux SA (France), Merck KGaA (Germany), Danaher (U.S.), Accelerate Diagnostics, Inc. (U.S.), NuMedii, Inc. (U.S.), and BacterioScan, Inc. (U.S.)
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials